{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T20:00:19Z","timestamp":1700164819678},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,2,15]],"date-time":"2003-02-15T00:00:00Z","timestamp":1045267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s00262-002-0364-5","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T02:54:52Z","timestamp":1576119292000},"page":"215-225","source":"Crossref","is-referenced-by-count":7,"title":["Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells"],"prefix":"10.1007","volume":"52","author":[{"given":"\u00d8ystein","family":"Bruserud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elling","family":"Ulvestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,2,15]]},"reference":[{"key":"0364_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00062752-200007000-00002","volume":"7","author":"Berman","year":"2000","unstructured":"Berman E (2000) Recent advances in the treatment of acute leukemia: 1999. Curr Opin Hematol 7:205","journal-title":"Curr Opin Hematol"},{"key":"0364_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s002620050481","volume":"46","author":"Bruserud","year":"1998","unstructured":"Bruserud \u00d8 (1998) Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic cells. Cancer Immunol Immunother 46:221","journal-title":"Cancer Immunol Immunother"},{"key":"0364_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj\/leu\/2401452","volume":"13","author":"Bruserud","year":"1999","unstructured":"Bruserud \u00d8 (1999) Acute myelogenous leukaemia blasts as accessory cells during T lymphocyte activation; possible implications for future therapeutic strategies. Leukemia 13:1175","journal-title":"Leukemia"},{"key":"0364_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0022-1759(84)90063-2","volume":"71","author":"Bruserud","year":"1984","unstructured":"Bruserud \u00d8, Moen T (1984) Production of Interleukin 2-containing growth medium for cloning of human T lymphocytes. J Immunol Methods 71:175","journal-title":"J Immunol Methods"},{"key":"0364_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/152581699320199","volume":"8","author":"Bruserud","year":"1999","unstructured":"Bruserud \u00d8, Ulvestad E (1999) Effects of \u03b3-irradiation on acute myelogenous leukaemia blasts; in vitro studies of proliferation, constitutive cytokine secretion and accessory cell function during T cell activation. J Hematother Stem Cell Res 8:431","journal-title":"J Hematother Stem Cell Res"},{"key":"0364_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/cimm.2000.1725","volume":"206","author":"Bruserud","year":"2000","unstructured":"Bruserud \u00d8, Giertsen BT, Ulvestad E (2000) Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol 206:36","journal-title":"Cell Immunol"},{"key":"0364_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0145-2126(01)00165-5","volume":"26","author":"Bruserud","year":"2002","unstructured":"Bruserud \u00d8, Ulvestad E (2002) Expression of Fc\u03b5-receptors by human acute myelogenous leukemia (AML) blasts; studies of high- and low- (CD23) affinity receptor expression and the effects of IgE-mediated receptor ligation on functional AML blast characteristics. Leuk Res 26:515","journal-title":"Leuk Res"},{"key":"0364_CR8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14712598.1.6.1005","volume":"1","author":"Bruserud","year":"2001","unstructured":"Bruserud \u00d8, Wendelbo \u00d8 (2001) Biological treatment in acute myelogenous leukemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy? Exp Opin Biol Ther 1:1005","journal-title":"Exp Opin Biol Ther"},{"key":"0364_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0609.1992.tb01589.x","volume":"48","author":"Bruserud","year":"1992","unstructured":"Bruserud \u00d8, Hamann W, Patel S, Ehninger G, Pawelec G (1992) IL-2- and IL-4-dependent proliferation of T cell clones derived early after allogeneic bone marrow transplantation: studies of patients with chronic myelogenous leukaemia. Eur J Haematol 48:221","journal-title":"Eur J Haematol"},{"key":"0364_CR10","first-page":"1910","volume":"9","author":"Bruserud","year":"1995","unstructured":"Bruserud \u00d8, Gjertsen BT, Brustugun OT, Bass\u00f8e CF, Nesthus I, Akselsen PE, B\u00fchring H-J, Pawelec G (1995) Effects of Interleukin 10 on blast cells derived from patients with acute myelogenous leukaemia. Leukemia 9:1910","journal-title":"Leukemia"},{"key":"0364_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s002620050334","volume":"43","author":"Bruserud","year":"1996","unstructured":"Bruserud \u00d8, Mentzoni L, Foss B, Bergheim J, Berentsen S, Nesthus I (1996) Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of allostimulated interferon-gamma secretion. Cancer Immunol Immunother 43:275","journal-title":"Cancer Immunol Immunother"},{"key":"0364_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1365-3083.1998.00254.x","volume":"47","author":"Bruserud","year":"1998","unstructured":"Bruserud \u00d8, Ulvestad E, Berentsen S, Bergheim J, Nesthus I (1998) T lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T cell proliferation. Scand J Immunol 47:54","journal-title":"Scand J Immunol"},{"key":"0364_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/stemcells.19-1-1","volume":"19","author":"Bruserud","year":"2001","unstructured":"Bruserud \u00d8, Gjertsen BT, Foss B, Huang T-S (2001) New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells\u2014the present use in experimental studies and the possible importance for future therapeutic strategies. Stem Cells 19:1","journal-title":"Stem Cells"},{"key":"0364_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","volume":"88","author":"Cardoso","year":"1996","unstructured":"Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billett A, Sallan SE, Gribben JG, Nadler LM (1996) Pre-B acute lymphoblastic leukemia cells may induce T cell anergy. Blood 88:41","journal-title":"Blood"},{"key":"0364_CR15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood.V90.2.549","volume":"90","author":"Cardoso","year":"1997","unstructured":"Cardoso AA, Seamon MJ, Afonso HM, Ghia P, Boussiotis VA, Freeman GJ, Gribben JG, Sallan SE, Nadler LM (1997) Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood 90:549","journal-title":"Blood"},{"key":"0364_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4613-1261-1_13","volume":"84","author":"Cortes","year":"1996","unstructured":"Cortes JE, Kantarjian H, Freireich EJ (1996) Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer Treat Res 84:291","journal-title":"Cancer Treat Res"},{"key":"0364_CR17","first-page":"87","volume":"10","author":"Costello","year":"1999","unstructured":"Costello RT, Mallet F, Chambost H, Sainty D, Gastaut JA, Olive D (1999) Differential modulation of immune recognition molecules by interleukin 7 in human acute leukaemias. Eur Cytokine Netw 10:87","journal-title":"Eur Cytokine Netw"},{"key":"0364_CR18","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","volume":"91","author":"Faderl","year":"1998","unstructured":"Faderl S, Kantarjian HM, Talpaz M, Estrov Z (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91:3995","journal-title":"Blood"},{"key":"0364_CR19","unstructured":"Gribben JG, Cardoso AA, Schultze JL, Nadler LM (1997) Biologic response modifiers in acute lymphoblastic leukemia. Leukemia 11 [Suppl 4]:S31"},{"key":"0364_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1040-8428(00)00097-4","volume":"36","author":"Hoelzer","year":"2000","unstructured":"Hoelzer D, Gokbuget N (2000) Recent approaches in acute lymphoblastic leukemia in adults. Crit Rev Oncol Hematol 36:49","journal-title":"Crit Rev Oncol Hematol"},{"key":"0364_CR21","first-page":"112","volume":"69","author":"Kasai","year":"1999","unstructured":"Kasai M, Akatsuka Y, Emi N, Taji H, Kohno A, Abe A, Tanimoto M, Kodera Y, Saito H (1999) Immune response of posttransplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1. Int J Hematol 69:112","journal-title":"Int J Hematol"},{"key":"0364_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1634\/stemcells.18-2-139","volume":"18","author":"Kohler","year":"2000","unstructured":"Kohler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhauser M (2000) Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 18:139","journal-title":"Stem Cells"},{"key":"0364_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1006\/cimm.1999.1504","volume":"194","author":"Murphy","year":"1999","unstructured":"Murphy LL, Mazanet MM, Taylor AC, Mestas J, Hughes CC (1999) Single-cell analysis of costimulation by B cells, endothelial cells, and fibroblasts demonstrates heterogeneity in responses of CD4+ memory T cells. Cell Immunol 194:150","journal-title":"Cell Immunol"},{"key":"0364_CR24","first-page":"55","volume":"57","author":"O'Flynn","year":"1986","unstructured":"O'Flynn K, Russul-Saib M, Ando I, Wallace DL, Beverley PCL, Boylston AW, Linch DC (1986) Different pathways of human T cell activation revealed by PHA-P and PHA-M. Immunology 57:55","journal-title":"Immunology"},{"key":"0364_CR25","first-page":"123","volume":"8","author":"Pawelec","year":"1994","unstructured":"Pawelec G (1994) Immune surveillance in leukaemia: rationale for immunotherapy? Hematol Rev 8:123","journal-title":"Hematol Rev"},{"key":"0364_CR26","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V88.6.2118.bloodjournal8862118","volume":"88","author":"Pawelec","year":"1996","unstructured":"Pawelec G, Max H, Halder T, Bruserud \u00d8, Merl A, da Silva P, Kalbacher H (1996) BCR\/ABL leukemia oncogen fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood 88:2118","journal-title":"Blood"},{"key":"0364_CR27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0952-7915(97)80085-4","volume":"9","author":"Shores","year":"1997","unstructured":"Shores EW, Love PE (1997) TCR\u03be chain in T cell development and selection. Curr Opin Immunol 9:380","journal-title":"Curr Opin Immunol"},{"key":"0364_CR28","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.139.9.2873","volume":"139","author":"van","year":"1987","unstructured":"van Lier RAW, Boot JHA, Verhoeven AJ, de Groot ER, Brouwer M, Aarden LA (1987) Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell independent induction of interleukin 2 responsiveness in T cells by \u03b5-anti-CD3. J Immunol 139:2873","journal-title":"J Immunol"},{"key":"0364_CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002620050476","volume":"46","author":"Whiteside","year":"1998","unstructured":"Whiteside TL, Rabinowich H (1998) The role of Fas\/FasL in immunosuppression induced by human tumors. Cancer Immunol Immunother 46:175","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-002-0364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-002-0364-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-002-0364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:01:58Z","timestamp":1695506518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-002-0364-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,15]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["0364"],"URL":"https:\/\/doi.org\/10.1007\/s00262-002-0364-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,15]]}}}